Telecoms Today
SEE OTHER BRANDS

Catch up with telecommunications news from the world

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 25, 2025

XRP News: Just 72 Hours Left to Join XploraDEX Presale, As XPL Token Distribution Nears Completion

XRP News: Just 72 Hours Left to Join XploraDEX Presale, As XPL Token Distribution Nears Completion

ZURICH, Switzerland, April 25, 2025 (GLOBE NEWSWIRE) -- The final countdown is officially on. With just 72 hours remaining in the XploraDEX presale and the $XPL token distribution nearly complete, the window to join one of the XRP Ledger’s most …

Discovery Announces Management Appointments

Discovery Announces Management Appointments

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce the following management appointments: Pierre Rocque as Chief Operating Officer; Jennifer Wagner as Executive …

Unlock Your Glutes Under Review: Best Functional Movement Training Program for a Stronger & Rounder Butt

Unlock Your Glutes Under Review: Best Functional Movement Training Program for a Stronger & Rounder Butt

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- You’ve tried the squats. You’ve done the lunges. You’ve followed the “booty band” trends and TikTok workouts that promise peach-perfect glutes in 10 days. And yet… something’s missing. Your glutes still …

Pangu Launches Otherworlds.ai, a Fully On-Chain Web3 Strategy Game Powered by AI

Pangu Launches Otherworlds.ai, a Fully On-Chain Web3 Strategy Game Powered by AI

Singapore, April 25, 2025 (GLOBE NEWSWIRE) -- Developer Pangu has released Otherworlds.ai, a lightweight, AI-powered strategy game that is optimized for instant browser play and offers complete on-chain transparency. This follows the success of MetaCene, …

SleepFuel Under Review: Best Natural Sleep Aid Supplement using an Oral Spray Formula

SleepFuel Under Review: Best Natural Sleep Aid Supplement using an Oral Spray Formula

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- For some, falling asleep takes hours. For others, it’s waking up at 2 AM and staring at the ceiling in silence. It’s not just frustrating. It’s exhausting. And many people avoid melatonin because it messes …

PrimeBiome Blue Antioxidant Method for Skin Reviewed: Discover Side Effects Risk Before Buying

PrimeBiome Blue Antioxidant Method for Skin Reviewed: Discover Side Effects Risk Before Buying

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: How the PrimeBiome Blue Antioxidant Method supports skin health through internal gut balance. Why digestive wellness is key to reducing breakouts, inflammation, and signs …

Best Probiotics For Women: Top-Rated Picks for Digestion, Mood, and Immunity Announced By WhatBest.

Best Probiotics For Women: Top-Rated Picks for Digestion, Mood, and Immunity Announced By WhatBest.

New York, April 25, 2025 (GLOBE NEWSWIRE) -- WhatBest, a leading authority known for meticulous, research-based evaluations of health and wellness products, is excited to announce its comprehensive list of the best probiotics specifically chosen for women. …

Tevogen Bio Announces 2025 Annual Meeting

Tevogen Bio Announces 2025 Annual Meeting

WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …

XRP News: Only 3 Days Left to Join XploraDEX Presale as $XPL Token Distribution Enters Final Stage

XRP News: Only 3 Days Left to Join XploraDEX Presale as $XPL Token Distribution Enters Final Stage

ZURICH, April 25, 2025 (GLOBE NEWSWIRE) -- The $XPL token distribution is now in its final stage, and the presale that has powered one of XRPL’s most anticipated launches is down to its last 4 days. With the window for early access rapidly closing, traders …

XRP News: XenDex Surpasses 10% Presale Allocation Within Hours of Launch

XRP News: XenDex Surpasses 10% Presale Allocation Within Hours of Launch

SYDNEY, April 25, 2025 (GLOBE NEWSWIRE) -- XenDex the first cross-chain decentralized exchange on the XRP Ledger, offering AI-assisted copy trading, non-custodial lending and borrowing, and seamless interoperability across blockchain networks is currently …

Priority Income Fund Announces Intent to Seek Public Listing of Shares of Common Stock

Priority Income Fund Announces Intent to Seek Public Listing of Shares of Common Stock

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”) is pleased to announce today that the Fund intends to seek to list shares of its common stock on a national securities exchange, with a target …

PER® Presents More Than a Dozen Free CME/CE Symposia at the Annual Oncology Meeting in Chicago

PER® Presents More Than a Dozen Free CME/CE Symposia at the Annual Oncology Meeting in Chicago

CHICAGO, April 25, 2025 (GLOBE NEWSWIRE) -- This May, during one of the most important weeks in cancer care, Physicians’ Education Resource®, LLC (PER®), the go-to educational resource for health care professionals across all specialties to advance patient …

Advanced BioNutritionals Under Review: Highly-Trusted Supplement Brand for Quality Products

Advanced BioNutritionals Under Review: Highly-Trusted Supplement Brand for Quality Products

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The most common supplement-related health concerns people face today Why supplement quality, formulation, and transparency matter more than ever How Advanced …

SightFresh Under Review: Secret Vision Berry to Restore Eyesight with Sight Fresh Ingredients

SightFresh Under Review: Secret Vision Berry to Restore Eyesight with Sight Fresh Ingredients

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The hidden causes behind the sharp rise in vision problems in 2025 How digital screens, pollution, and aging contribute to visual decline What the SightFresh supplement is, …

Top Technology Executives Recognized at the 2025 HoustonCIO ORBIE Awards

Top Technology Executives Recognized at the 2025 HoustonCIO ORBIE Awards

Leading CIOs honored for leadership, innovation, and business impact.  HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- The 2025 HoustonCIO ORBIE Awards recognized the exceptional leadership and innovation of top technology executives from Chevron, NOV, Nabors, …

HPQ Silicium : Correction de communiqués antérieurs

HPQ Silicium : Correction de communiqués antérieurs

En réponse à une demande formulée par l’Autorité des marchés financiers, HPQ Silicium procède à la publication d’un communiqué rectificatif visant à corriger certaines informations à caractère prospectif diffusées dans des communiqués antérieurs. MONTRÉAL, …

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service